Propofol but not dexmedetomidine produce locomotor sensitization via nitric oxide in rats. 2021

Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
Faculty of Medicine, Department of Medical Pharmacology, Beykent University, Istanbul, Turkey.

BACKGROUND The abused potential of some anesthetics has been debated. Measurement of locomotor sensitization is a better way to detect the neurobehavioral plasticity of addiction. OBJECTIVE The present study aims to explore whether propofol and dexmedetomidine are capable of inducing locomotor sensitization. METHODS Male Wistar rats (250-300 g) were the subjects (n = 8 for each group). Propofol (20 and 40 mg/kg) and dexmedetomidine (2.5-20 μg/kg) or saline were injected to rats intraperitoneally (IP), and their locomotor activities were recorded for 15 min. Consequently, L-NAME (30 and 60 mg/kg)-a nitric oxide (NO) inhibitory agent-was injected to rats 30 min before propofol (40 mg/kg) or saline injections, and the locomotor activity was recorded. The process was carried out for 13 days, with 7 sessions applied every other day. RESULTS Dexmedetomidine did not produce any significant locomotor sensitization. While propofol (20 mg/kg) produced a significant locomotor sensitization in the last treatment session (day 13), at the higher dose, it prompted a significant locomotor sensitization from the 3rd treatment session. L-NAME blocked propofol-induced locomotor hyperactivity and sensitization significantly without producing any noteworthy changes on the locomotor activity during the testing period of 13 days when administered alone. CONCLUSIONS Our results suggest that propofol but not dexmedetomidine produced a significant locomotor sensitization via central nitrergic system. Dexmedetomidine may have a lesser psychostimulant type addictive potential than propofol. Sensitization development by propofol implies that this drug might be effective on the neuroadaptive processes associated with a stimulant type of dependence.

UI MeSH Term Description Entries
D008124 Locomotion Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms. Locomotor Activity,Activities, Locomotor,Activity, Locomotor,Locomotor Activities
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015742 Propofol An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS. Disoprofol,2,6-Bis(1-methylethyl)phenol,2,6-Diisopropylphenol,Aquafol,Diprivan,Disoprivan,Fresofol,ICI-35,868,ICI-35868,Ivofol,Propofol Abbott,Propofol Fresenius,Propofol MCT,Propofol Rovi,Propofol-Lipuro,Recofol,2,6 Diisopropylphenol,ICI 35,868,ICI 35868,ICI35,868,ICI35868
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
September 2001, Hiroshima journal of medical sciences,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
July 2001, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
July 2008, Psychopharmacology,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
January 2001, Physiology & behavior,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
November 2004, Hormones and behavior,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
August 2006, American journal of hypertension,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
July 2023, British journal of anaesthesia,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
September 2016, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
March 1999, Pain,
Tuğçe Uskur, and Ayşe Özçetin Şenöz, and Burcu Çevreli, and Aydın Barlas, and Tayfun Uzbay
April 2005, Psychopharmacology,
Copied contents to your clipboard!